{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T22:23:01Z","timestamp":1791066181622,"version":"4.1.0"},"publisher-location":"Berlin, Heidelberg","reference-count":98,"publisher":"Springer Berlin Heidelberg","isbn-type":[{"value":"9783540921646","type":"print"},{"value":"9783540921653","type":"electronic"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009]]},"DOI":"10.1007\/978-3-540-92165-3_18","type":"book-chapter","created":{"date-parts":[[2009,9,18]],"date-time":"2009-09-18T14:32:36Z","timestamp":1253284356000},"page":"369-393","source":"Crossref","is-referenced-by-count":118,"title":["Microneedle-Based Vaccines"],"prefix":"10.1007","author":[{"given":"Mark R.","family":"Prausnitz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A.","family":"Mikszta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Cormier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander K.","family":"Andrianov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,8,4]]},"reference":[{"key":"18_CR1_18","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.jhin.2005.05.015","volume":"61","author":"D Adams","year":"2005","unstructured":"Adams D, Quayum M, Worthington T, Lambert P, Elliott T (2005) Evaluation of a 2% chlorhexidine gluconate in 70% isopropyl alcohol skin disinfectant. J Hosp Infect 61:287\u2013290","journal-title":"J Hosp Infect"},{"key":"18_CR2_18","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1128\/CVI.00387-06","volume":"14","author":"JB Alarcon","year":"2007","unstructured":"Alarcon JB, Hartley AW, Harvey NG, Mikszta JA (2007) Preclinical evaluation of microneedle technology for intradermal delivery of influenza vaccines. Clin Vaccine Immunol 14:375\u2013381","journal-title":"Clin Vaccine Immunol"},{"key":"18_CR3_18","doi-asserted-by":"crossref","first-page":"472","DOI":"10.2340\/0001555565472478","volume":"65","author":"KE Andersen","year":"1985","unstructured":"Andersen KE, Boman A, Volund A, Wahlberg JE (1985) Induction of formaldehyde contact sensitivity: dose response relationship in the guinea pig maximization test. Acta Derm Venereol 65:472\u2013478","journal-title":"Acta Derm Venereol"},{"key":"18_CR4_18","first-page":"1","volume":"51","author":"WL Atkinson","year":"2002","unstructured":"Atkinson WL, Pickering LK, Schwartz B, Weniger BG, Iskander JK, Watson JC (2002) General recommendations on immunization. Recommendations of the Advisory Committee on Immunization Practices (ACIP) and the American Academy of Family Physicians (AAFP). MMWR Recomm Rep 51:1\u201335","journal-title":"MMWR Recomm Rep"},{"key":"18_CR5_18","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.vaccine.2006.08.026","volume":"25","author":"P Auewarakul","year":"2007","unstructured":"Auewarakul P, Kositanont U, Sornsathapornkul P, Tothong P, Kanyok R, Thongcharoen P (2007) Antibody responses after dose-sparing intradermal influenza vaccination. Vaccine 25:659\u2013663","journal-title":"Vaccine"},{"key":"18_CR6_18","first-page":"315","volume-title":"Clinically applied microcirculation research","author":"JH Barker","year":"1995","unstructured":"Barker JH, Ryan TJ (1995) Skin microcirculation In: Barker JH, Anderson GL, Menger MD (eds) Clinically applied microcirculation research. CRC, Boca Raton, pp 315\u2013338"},{"key":"18_CR7_18","doi-asserted-by":"publisher","first-page":"2286","DOI":"10.1056\/NEJMoa043555","volume":"351","author":"RB Belshe","year":"2004","unstructured":"Belshe RB, Newman FK, Cannon J, Duane C, Treanor J, Van Hoecke C, Howe BJ, Dubin G (2004) Serum antibody responses after intradermal vaccination against influenza. N Engl J Med 351:2286\u20132294","journal-title":"N Engl J Med"},{"key":"18_CR8_18","doi-asserted-by":"publisher","first-page":"6755","DOI":"10.1016\/j.vaccine.2007.06.066","volume":"25","author":"RB Belshe","year":"2007","unstructured":"Belshe RB, Newman FK, Wilkins K, Graham IL, Babusis E, Ewell M, Frey SE (2007) Comparative immunogenicity of trivalent influenza vaccine administered by intradermal or intramuscular route in healthy adults. Vaccine 25:6755\u20136763","journal-title":"Vaccine"},{"key":"18_CR9_18","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1080\/10611860500383705","volume":"13","author":"J Birchall","year":"2005","unstructured":"Birchall J, Coulman S, Pearton M, Allender C, Brain K, Anstey A, Gateley C, Wilke N, Morrissey A (2005) Cutaneous DNA delivery and gene expression in ex vivo human skin explants via wet-etch micro-fabricated micro-needles. J Drug Target 13:415\u2013421","journal-title":"J Drug Target"},{"key":"18_CR10_18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1586\/17434440.3.1.1","volume":"3","author":"JC Birchall","year":"2006","unstructured":"Birchall JC (2006) Microneedle array technology: the time is right but is the science ready? Expert Rev Med Devices 3:1\u20134","journal-title":"Expert Rev Med Devices"},{"key":"18_CR11_18","doi-asserted-by":"crossref","DOI":"10.1201\/9780849359033","volume-title":"Percutaneous absorption","author":"RL Bronaugh","year":"2005","unstructured":"Bronaugh RL, Maibach HI (2005) Percutaneous absorption. Marcel Dekker, New York"},{"issue":"uppl","key":"18_CR12_18","doi-asserted-by":"crossref","first-page":"S466","DOI":"10.1093\/infdis\/136.Supplement_3.S466","volume":"136","author":"H Brown","year":"1977","unstructured":"Brown H, Kasel JA, Freeman DM, Moise LD, Grose NP, Couch RB (1977) The immunizing effect of influenza A\/New Jersey\/76 (Hsw1N1) virus vaccine administered intradermally and intramuscularly to adults. J Infect Dis 136(suppl):S466\u2013S471","journal-title":"J Infect Dis"},{"key":"18_CR13_18","first-page":"682","volume":"56","author":"Centers for Disease Control and Prevention (CDC)","year":"2007","unstructured":"Centers for Disease Control and Prevention (CDC) (2007) Progress toward interruption of wild poliovirus transmission worldwide, January 2006\u2013May 2007. MMWR Morb Mortal Wkly Rep 56:682\u2013685","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"18_CR14_18","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1111\/j.1365-2133.2004.05921.x","volume":"150","author":"F Chabri","year":"2004","unstructured":"Chabri F, Bouris K, Jones T, Barrow D, Hann A, Allender C, Brain K, Birchall J (2004) Microfabricated silicon microneedles for nonviral cutaneous gene delivery. Br J Dermatol 150:869\u2013877","journal-title":"Br J Dermatol"},{"key":"18_CR15_18","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1542\/peds.2006-3176","volume":"119","author":"SS Chiu","year":"2007","unstructured":"Chiu SS, Peiris JS, Chan KH, Wong WH, Lau YL (2007) Immunogenicity and safety of intradermal influenza immunization at a reduced dose in healthy children. Pediatrics 119:1076\u20131082","journal-title":"Pediatrics"},{"key":"18_CR16_18","first-page":"589","volume-title":"Modified-release drug delivery technology","author":"M Cormier","year":"2003","unstructured":"Cormier M, Daddona PE (2003) Macroflux technology for transdermal delivery of therapeutic proteins and vaccines. In: Rathbone MJ, Hadgraft J, Roberts MS (eds) Modified-release drug delivery technology. Marcel Dekker, New York, pp 589\u2013598"},{"key":"18_CR17_18","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/S0168-3659(04)00171-3","volume":"97","author":"M Cormier","year":"2004","unstructured":"Cormier M, Johnson B, Ameri M, Nyam K, Libiran L, Zhang DD, Daddona P (2004) Transdermal delivery of desmopressin using a coated microneedle array patch system. J Control Release 97:503\u2013511","journal-title":"J Control Release"},{"key":"18_CR18_18","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v23.i3.20","volume":"23","author":"S Coulman","year":"2006a","unstructured":"Coulman S, Allender C, Birchall J (2006a) Microneedles and other physical methods for overcoming the stratum corneum barrier for cutaneous gene therapy. Crit Rev Ther Drug Carrier Syst 23:205\u2013258","journal-title":"Crit Rev Ther Drug Carrier Syst"},{"key":"18_CR19_18","doi-asserted-by":"publisher","first-page":"65","DOI":"10.2174\/156720106775197510","volume":"3","author":"SA Coulman","year":"2006b","unstructured":"Coulman SA, Barrow D, Anstey A, Gateley C, Morrissey A, Willke N, Allender C, Brain K, Birchall JC (2006b) Minimally invasive delivery of macromolecules and plasmid DNA via microneedles. Curr Drug Deliv 3:65\u201375","journal-title":"Curr Drug Deliv"},{"key":"18_CR20_18","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1016\/j.jbiomech.2003.12.010","volume":"37","author":"SP Davis","year":"2004","unstructured":"Davis SP, Landis BJ, Adams ZH, Allen MG, Prausnitz MR (2004) Insertion of microneedles into skin: measurement and prediction of insertion force and needle fracture force. J Biomech 37:1155\u20131163","journal-title":"J Biomech"},{"key":"18_CR21_18","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1109\/TBME.2005.845240","volume":"52","author":"SP Davis","year":"2005","unstructured":"Davis SP, Martanto W, Allen MG, Prausnitz MR (2005) Transdermal insulin delivery to diabetic rats through microneedles. IEEE Trans Biomed Eng 52:909\u2013915","journal-title":"IEEE Trans Biomed Eng"},{"key":"18_CR22_18","doi-asserted-by":"publisher","first-page":"106","DOI":"10.4161\/hv.1.3.1797","volume":"1","author":"CH Dean","year":"2005","unstructured":"Dean CH, Alarcon JB, Waterston AM, Draper K, Early R, Guirakhoo F, Monath TP, Mikszta JA (2005) Cutaneous delivery of a live, attenuated chimeric flavivirus vaccine against Japanese encephalitis (ChimeriVax-JE) in non-human primates. Hum Vaccin 1:106\u2013111","journal-title":"Hum Vaccin"},{"key":"18_CR23_18","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1006\/biol.1994.1006","volume":"22","author":"JL Diaz-Ortega","year":"1994","unstructured":"Diaz-Ortega JL, Forsey T, Clements CJ, Milstien J (1994) The relationship between dose and response of standard measles vaccines. Biologicals 22:35\u201344","journal-title":"Biologicals"},{"key":"18_CR24_18","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/BF02962244","volume":"26","author":"PD Ellner","year":"1998","unstructured":"Ellner PD (1998) Smallpox: gone but not forgotten. Infection 26:263\u2013269","journal-title":"Infection"},{"key":"18_CR25_18","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3201\/eid1201.050983","volume":"12","author":"AS Fauci","year":"2006","unstructured":"Fauci AS (2006) Pandemic influenza threat and preparedness. Emerg Infect Dis 12:73\u201377","journal-title":"Emerg Infect Dis"},{"key":"18_CR26_18","unstructured":"Freking K (2005) Health News: HHS may use mail to deliver emergency meds. http:\/\/www.health-news.org\/breaking\/2885\/hhs-may-use-mail-to-deliver-emergency-meds.html Accessed 30 Oct 2007"},{"key":"18_CR27_18","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1109\/JMEMS.2003.820293","volume":"6","author":"JGE Gardeniers","year":"2003","unstructured":"Gardeniers JGE, Luttge R, Berenschot JW, de Boer MJ, Yeshurun Y, Hefetz M, van \u2018t Oever R, van den Berg A (2003) Silicon micromachined hollow microneedles for transdermal liquid transport. J MEMS 6:855\u2013862","journal-title":"J MEMS"},{"key":"18_CR28_18","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.jconrel.2006.10.017","volume":"117","author":"HS Gill","year":"2007a","unstructured":"Gill HS, Prausnitz MR (2007a) Coated microneedles for transdermal delivery. J Control Release 117:227\u2013237","journal-title":"J Control Release"},{"key":"18_CR29_18","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1007\/s11095-007-9286-4","volume":"24","author":"HS Gill","year":"2007a","unstructured":"Gill HS, Prausnitz MR (2007b) Coating formulations for microneedles. Pharm Res 24:1369\u20131380","journal-title":"Pharm Res"},{"key":"18_CR30_18","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1016\/j.jpcs.2007.10.059","volume":"69","author":"HS Gill","year":"2008","unstructured":"Gill HS, Prausnitz MR (2008) Pocketed microneedles for drug delivery to the skin. J Phys Chem Solids 69:1537\u20131541","journal-title":"J Phys Chem Solids"},{"key":"18_CR31_18","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1097\/AJP.0b013e31816778f9","volume":"24","author":"HS Gill","year":"2008","unstructured":"Gill HS, Denson DD, Burris B, Prausnitz MR (2008) Effect of microneedle design on pain in human subjects Clin J Pain 24:585\u2013594","journal-title":"Clin J Pain"},{"key":"18_CR32_18","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1001\/jama.295.5.554","volume":"295","author":"LO Gostin","year":"2006","unstructured":"Gostin LO (2006) Medical countermeasures for pandemic influenza: ethics and the law. JAMA 295:554\u2013556","journal-title":"JAMA"},{"key":"18_CR33_18","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.2105\/AJPH.69.12.1247","volume":"69","author":"W Halperin","year":"1979","unstructured":"Halperin W, Weiss WI, Altman R, Diamond MA, Black KJ, Iaci AW, Black HC, Goldfield M (1979) A comparison of the intradermal and subcutaneous routes of influenza vaccination with A\/New Jersey\/76 (swine flu) and A\/Victoria\/75: report of a study and review of the literature. Am J Public Health 69:1247\u20131251","journal-title":"Am J Public Health"},{"key":"18_CR34_18","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1021\/js980042+","volume":"87","author":"S Henry","year":"1998","unstructured":"Henry S, McAllister DV, Allen MG, Prausnitz MR (1998) Microfabricated microneedles: a novel approach to transdermal drug delivery. J Pharm Sci 87:922\u2013925","journal-title":"J Pharm Sci"},{"key":"18_CR35_18","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1093\/infdis\/140.2.234","volume":"140","author":"FA Herbert","year":"1979","unstructured":"Herbert FA, Larke RP, Markstad EL (1979) Comparison of responses to influenza A\/New Jersey\/76-A\/Victoria\/75 virus vaccine administered intradermally or subcutaneously to adults with chronic respiratory disease. J Infect Dis 140:234\u2013238","journal-title":"J Infect Dis"},{"key":"18_CR36_18","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1016\/j.vaccine.2006.11.017","volume":"25","author":"JW Hooper","year":"2007","unstructured":"Hooper JW, Golden JW, Ferro AM, King AD (2007) Smallpox DNA vaccine delivered by novel skin electroporation device protects mice against intranasal poxvirus challenge. Vaccine 25:1814\u20131823","journal-title":"Vaccine"},{"key":"18_CR37_18","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s00281-007-0059-2","volume":"29","author":"CM Huang","year":"2007","unstructured":"Huang CM (2007) Topical vaccination: the skin as a unique portal to adaptive immune responses. Semin Immunopathol 29:71\u201380","journal-title":"Semin Immunopathol"},{"key":"18_CR38_18","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.ejps.2006.05.011","volume":"29","author":"Y Ito","year":"2006a","unstructured":"Ito Y, Hagiwara E, Saeki A, Sugioka N, Takada K (2006a) Feasibility of microneedles for percutaneous absorption of insulin. Eur J Pharm Sci 29:82\u201388","journal-title":"Eur J Pharm Sci"},{"key":"18_CR39_18","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1080\/10611860600785080","volume":"14","author":"Y Ito","year":"2006b","unstructured":"Ito Y, Yoshimitsu J, Shiroyama K, Sugioka N, Takada K (2006b) Self-dissolving microneedles for the percutaneous absorption of EPO in mice. J Drug Target 14:255\u2013261","journal-title":"J Drug Target"},{"key":"18_CR40_18","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1097\/00000539-200102000-00041","volume":"92","author":"S Kaushik","year":"2001","unstructured":"Kaushik S, Hord AH, Denson DD, McAllister DV, Smitra S, Allen MG, Prausnitz MR (2001) Lack of pain associated with microfabricated microneedles. Anesth Analg 92:502\u2013504","journal-title":"Anesth Analg"},{"key":"18_CR41_18","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1056\/NEJMoa043540","volume":"351","author":"RT Kenney","year":"2004","unstructured":"Kenney RT, Frech SA, Muenz LR, Villar CP, Glenn GM (2004) Dose sparing with intradermal injection of influenza vaccine. N Engl J Med 351:2295\u20132301","journal-title":"N Engl J Med"},{"key":"18_CR42_18","doi-asserted-by":"publisher","first-page":"2330","DOI":"10.1056\/NEJMe048314","volume":"351","author":"JR La Montagne","year":"2004","unstructured":"La Montagne JR, Fauci AS (2004) Intradermal influenza vaccination\u2014can less be more? N Engl J Med 351:2330\u20132332","journal-title":"N Engl J Med"},{"key":"18_CR43_18","doi-asserted-by":"publisher","first-page":"3197","DOI":"10.1016\/j.vaccine.2008.03.095","volume":"26","author":"P-H Lambert","year":"2008","unstructured":"Lambert P-H, Laurent PE (2008) Intradermal vaccine delivery: will new delivery systems transform vaccine administration? Vaccine 26:3197\u20133208","journal-title":"Vaccine"},{"key":"18_CR44_18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1523-1747.2004.23554.x","volume":"124","author":"AT Larregina","year":"2005","unstructured":"Larregina AT, Falo LD Jr (2005) Changing paradigms in cutaneous immunology: adapting with dendritic cells. J Invest Dermatol 124:1\u201312","journal-title":"J Invest Dermatol"},{"key":"18_CR45_18","doi-asserted-by":"publisher","first-page":"8833","DOI":"10.1016\/j.vaccine.2007.10.020","volume":"25","author":"PE Laurent","year":"2007","unstructured":"Laurent PE, Bonnet S, Alchas P, Regolini P, Mikszta JA, Pettis R, Harvey NG (2007) Evaluation of the clinical performance of a new intradermal vaccine administration technique and associated delivery system. Vaccine 25:8833\u20138842","journal-title":"Vaccine"},{"key":"18_CR46_18","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1016\/j.biomaterials.2007.12.048","volume":"29","author":"J-W Lee","year":"2008","unstructured":"Lee J-W, Park J-H, Prausnitz MR (2008) Dissolving microneedles for transdermal drug delivery. Biomaterials 29:2113\u20132124","journal-title":"Biomaterials"},{"key":"18_CR47_18","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1023\/A:1013395102049","volume":"18","author":"W Lin","year":"2001","unstructured":"Lin W, Cormier M, Samiee A, Griffin A, Johnson B, Teng C, Hardee GE, Daddona P (2001) Transdermal delivery of antisense oligonucleotides with microprojection patch (Macroflux) technology. Pharm Res 18:1789\u20131793","journal-title":"Pharm Res"},{"key":"18_CR48_18","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1093\/infdis\/167.1.78","volume":"167","author":"PW Lowry","year":"1993","unstructured":"Lowry PW, Sabella C, Koropchak CM, Watson BN, Thackray HM, Abbruzzi GM, Arvin AM (1993) Investigation of the pathogenesis of varicella-zoster virus infection in guinea pigs by using polymerase chain reaction. J Infect Dis 167:78\u201383","journal-title":"J Infect Dis"},{"key":"18_CR49_18","unstructured":"Maa Y-F, Sellers S, Matriano J, Ramdas A (2005) Apparatus and method for transdermal delivery of influenza vaccine. US Pat Appl 20050220854"},{"key":"18_CR50_18","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1023\/B:PHAM.0000029282.44140.2e","volume":"21","author":"W Martanto","year":"2004","unstructured":"Martanto W, Davis S, Holiday N, Wang J, Gill H, Prausnitz M (2004) Transdermal delivery of insulin using microneedles in vivo. Pharm Res 21:947\u2013952","journal-title":"Pharm Res"},{"key":"18_CR51_18","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.jconrel.2006.02.017","volume":"112","author":"W Martanto","year":"2006a","unstructured":"Martanto W, Moore JS, Couse T, Prausnitz MR (2006a) Mechanism of fluid infusion during microneedle insertion and retraction. J Control Release 112:357\u2013361","journal-title":"J Control Release"},{"key":"18_CR52_18","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1007\/s11095-005-8498-8","volume":"23","author":"W Martanto","year":"2006b","unstructured":"Martanto W, Moore JS, Kashlan O, Kamath R, Wang PM, O\u2019Neal JM, Prausnitz MR (2006b) Microinfusion using hollow microneedles. Pharm Res 23:104\u2013113","journal-title":"Pharm Res"},{"key":"18_CR53_18","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1023\/A:1013607400040","volume":"19","author":"JA Matriano","year":"2002","unstructured":"Matriano JA, Cormier M, Johnson J, Young WA, Buttery M, Nyam K, Daddona PE (2002) Macroflux microprojection array patch technology: a new and efficient approach for intracutaneous immunization. Pharm Res 19:63\u201370","journal-title":"Pharm Res"},{"key":"18_CR54_18","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1146\/annurev.bioeng.2.1.289","volume":"2","author":"DV McAllister","year":"2000","unstructured":"McAllister DV, Allen MG, Prausnitz MR (2000) Microfabricated microneedles for gene and drug delivery. Annu Rev Biomed Eng 2:289\u2013313","journal-title":"Annu Rev Biomed Eng"},{"key":"18_CR55_18","doi-asserted-by":"publisher","first-page":"13755","DOI":"10.1073\/pnas.2331316100","volume":"100","author":"DV McAllister","year":"2003","unstructured":"McAllister DV, Wang PM, Davis SP, Park J-H, Canatella PJ, Allen MG, Prausnitz MR (2003) Microfabricated needles for transdermal delivery of macromolecules and nanoparticles: fabrication methods and transport studies. Proc Natl Acad Sci USA 100:13755\u201313760","journal-title":"Proc Natl Acad Sci USA"},{"key":"18_CR56_18","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/nm0402-415","volume":"8","author":"JA Mikszta","year":"2002","unstructured":"Mikszta JA, Alarcon JB, Brittingham JM, Sutter DE, Pettis RJ, Harvey NG (2002) Improved genetic immunization via micromechanical disruption of skin-barrier function and targeted epidermal delivery. Nat Med 8:415\u2013419","journal-title":"Nat Med"},{"key":"18_CR57_18","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1086\/426865","volume":"191","author":"JA Mikszta","year":"2005","unstructured":"Mikszta JA, Sullivan VJ, Dean C, Waterston AM, Alarcon JB, Dekker JP 3rd, Brittingham JM, Huang J, Hwang CR, Ferriter M, Jiang G, Mar K, Saikh KU, Stiles BG, Roy CJ, Ulrich RG, Harvey NG (2005) Protective immunization against inhalational anthrax: a comparison of minimally invasive delivery platforms. J Infect Dis 191:278\u2013288","journal-title":"J Infect Dis"},{"key":"18_CR58_18","doi-asserted-by":"publisher","first-page":"6806","DOI":"10.1128\/IAI.01210-06","volume":"74","author":"JA Mikszta","year":"2006","unstructured":"Mikszta JA, Dekker JP 3rd, Harvey NG, Dean CH, Brittingham JM, Huang J, Sullivan VJ, Dyas B, Roy CJ, Ulrich RG (2006) Microneedle-based intradermal delivery of the anthrax recombinant protective antigen vaccine. Infect Immun 74:6806\u20136810","journal-title":"Infect Immun"},{"key":"18_CR59_18","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s10544-005-3024-7","volume":"7","author":"T Miyano","year":"2005","unstructured":"Miyano T, Tobinaga Y, Kanno T, Matsuzaki Y, Takeda H, Wakui M, Hanada K (2005) Sugar micro needles as transdermic drug delivery system. Biomed Microdevices 7:185\u2013188","journal-title":"Biomed Microdevices"},{"key":"18_CR60_18","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/j.1346-8138.1992.tb03197.x","volume":"19","author":"H Miyauchi","year":"1992","unstructured":"Miyauchi H, Horio T (1992) A new animal model for contact dermatitis: the hairless guinea pig. J Dermatol 19:140\u2013145","journal-title":"J Dermatol"},{"key":"18_CR61_18","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1586\/14760584.4.4.553","volume":"4","author":"TP Monath","year":"2005","unstructured":"Monath TP (2005) Yellow fever vaccine. Expert Rev Vaccines 4:553\u2013574","journal-title":"Expert Rev Vaccines"},{"key":"18_CR62_18","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1086\/378356","volume":"188","author":"TP Monath","year":"2003","unstructured":"Monath TP, Guirakhoo F, Nichols R, Yoksan S, Schrader R, Murphy C, Blum P, Woodward S, McCarthy K, Mathis D, Johnson C, Bedford P (2003) Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis antigen. J Infect Dis 188:1213\u20131230","journal-title":"J Infect Dis"},{"key":"18_CR63_18","doi-asserted-by":"publisher","first-page":"2382","DOI":"10.1172\/JCI33349","volume":"117","author":"FO Nestle","year":"2007","unstructured":"Nestle FO, Nickoloff BJ (2007) Deepening our understanding of immune sentinels in the skin. J Clin Invest 117:2382\u20132385","journal-title":"J Clin Invest"},{"key":"18_CR64_18","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1007\/s11095-007-9256-x","volume":"24","author":"L Nordquist","year":"2007","unstructured":"Nordquist L, Roxhed N, Griss P, Stemme G (2007) Novel microneedle patches for active insulin delivery are efficient in maintaining glycaemic control: an initial comparison with subcutaneous administration. Pharm Res 24:1381\u20131388","journal-title":"Pharm Res"},{"key":"18_CR65_18","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1023\/B:PHAM.0000041443.17935.33","volume":"21","author":"DT O\u2019Hagan","year":"2004","unstructured":"O\u2019Hagan DT, Rappuoli R (2004) Novel approaches to vaccine delivery. Pharm Res 21:1519\u20131530","journal-title":"Pharm Res"},{"key":"18_CR66_18","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.jconrel.2005.02.002","volume":"104","author":"J-H Park","year":"2005","unstructured":"Park J-H, Allen MG, Prausnitz MR (2005) Biodegradable polymer microneedles: fabrication, mechanics and transdermal drug delivery. J Control Release 104:51\u201366","journal-title":"J Control Release"},{"key":"18_CR67_18","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1007\/s11095-006-0028-9","volume":"23","author":"JH Park","year":"2006","unstructured":"Park JH, Allen MG, Prausnitz MR (2006) Polymer microneedles for controlled-release drug delivery. Pharm Res 23:1008\u20131019","journal-title":"Pharm Res"},{"issue":"2","key":"18_CR68_18","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1007\/s11095-007-9360-y","volume":"25","author":"M Pearton","year":"2008","unstructured":"Pearton M, Allender C, Brain K, Anstey A, Gateley C, Wilke N, Morrissey A, Birchall J (2008) Gene delivery to the epidermal cells of human skin explants using microfabricated microneedles and hydrogel formulations. Pharm Res 25(2):407\u2013416","journal-title":"Pharm Res"},{"key":"18_CR69_18","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1586\/14760584.6.1.87","volume":"6","author":"DJ Pickup","year":"2007","unstructured":"Pickup DJ (2007) Understanding orthopoxvirus interference with host immune responses to inform novel vaccine design. Expert Rev Vaccines 6:87\u201395","journal-title":"Expert Rev Vaccines"},{"key":"18_CR70_18","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.addr.2003.10.023","volume":"56","author":"MR Prausnitz","year":"2004","unstructured":"Prausnitz MR (2004) Microneedles for transdermal drug delivery. Adv Drug Deliv Rev 56:581\u2013587","journal-title":"Adv Drug Deliv Rev"},{"key":"18_CR71_18","first-page":"497","volume-title":"Percutaneous absorption","author":"M Prausnitz","year":"2005","unstructured":"Prausnitz M (2005) Assessment of microneedles for transdermal drug delivery. In: Bronaugh R, Maibach H (eds) Percutaneous absorption. Marcel Dekker, New York, pp 497\u2013507"},{"key":"18_CR72_18","first-page":"513","volume-title":"Modified release drug delivery systems","author":"M Prausnitz","year":"2003","unstructured":"Prausnitz M, Ackley D, Gyory J (2003) Microneedles for transdermal drug delivery. In: Rathbone M, Hadgraft J, Roberts M (eds) Modified release drug delivery systems. Marcel Dekker, New York, pp 513\u2013522"},{"key":"18_CR73_18","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1038\/nbt.1504","volume":"26","author":"MR Prausnitz","year":"2008","unstructured":"Prausnitz MR, Langer R (2008) Transdermal drug delivery. Nat Biotech 26:1261\u20131268","journal-title":"Nat Biotech"},{"key":"18_CR74_18","first-page":"239","volume-title":"Percutaneous penetration enhancers","author":"M Prausnitz","year":"2005","unstructured":"Prausnitz M, Mikszta J, Raeder-Devens J (2005) Microneedles. In: Smith E, Maibach H (eds) Percutaneous penetration enhancers. CRC, Boca Raton, FL, pp 239\u2013255"},{"key":"18_CR75_18","volume-title":"Modified release drug delivery","author":"MR Prausnitz","year":"2008","unstructured":"Prausnitz MR, Gill HS, Park J-H (2008) Microneedles for drug delivery. In: Rathbone MJ, Hadgraft J, Roberts MS, Lane ME (eds) Modified release drug delivery. Informa Healthcare, New York"},{"key":"18_CR76_18","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1109\/JPROC.2003.820542","volume":"92","author":"ML Reed","year":"2004","unstructured":"Reed ML, Lye W-K (2004) Microsystems for drug and gene delivery. Proc IEEE 92:56\u201375","journal-title":"Proc IEEE"},{"key":"18_CR77_18","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/S0190-9622(89)70048-7","volume":"20","author":"RR Roth","year":"1989","unstructured":"Roth RR, James WD (1989) Microbiology of the skin: resident flora, ecology, infection. J Am Acad Dermatol 20:367\u2013390","journal-title":"J Am Acad Dermatol"},{"key":"18_CR78_18","first-page":"608","volume":"44","author":"DL Ruble","year":"1994","unstructured":"Ruble DL, Elliott JJ, Waag DM, Jaax GP (1994) A refined guinea pig model for evaluating delayed-type hypersensitivity reactions caused by Q fever vaccines. Lab Anim Sci 44:608\u2013612","journal-title":"Lab Anim Sci"},{"key":"18_CR79_18","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s10856-005-6444-2","volume":"16","author":"M Shirkhanzadeh","year":"2005","unstructured":"Shirkhanzadeh M (2005) Microneedles coated with porous calcium phosphate ceramics: effective vehicles for transdermal delivery of solid trehalose. J Mater Sci Mater Med 16:37\u201345","journal-title":"J Mater Sci Mater Med"},{"key":"18_CR80_18","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1111\/j.1600-0846.2005.00107.x","volume":"11","author":"RK Sivamani","year":"2005","unstructured":"Sivamani RK, Stoeber B, Wu GC, Zhai H, Liepmann D, Maibach H (2005) Clinical microneedle injection of methyl nicotinate: stratum corneum penetration. Skin Res Technol 11:152\u2013156","journal-title":"Skin Res Technol"},{"key":"18_CR81_18","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1517\/17425247.4.1.19","volume":"4","author":"RK Sivamani","year":"2007","unstructured":"Sivamani RK, Liepmann D, Maibach HI (2007) Microneedles and transdermal applications. Expert Opin Drug Deliv 4:19\u201325","journal-title":"Expert Opin Drug Deliv"},{"key":"18_CR82_18","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.immuni.2005.12.005","volume":"24","author":"K Subbarao","year":"2006","unstructured":"Subbarao K, Murphy BR, Fauci AS (2006) Development of effective vaccines against pandemic influenza. Immunity 24:5\u20139","journal-title":"Immunity"},{"key":"18_CR83_18","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1002\/adma.200701205","volume":"20","author":"SP Sullivan","year":"2008","unstructured":"Sullivan SP, Murthy N, Prausnitz MR (2008) Minimally invasive protein delivery with rapidly dissolving polymer microneedles. Adv Mat 20:933\u2013938","journal-title":"Adv Mat"},{"key":"18_CR84_18","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s10544-005-6171-y","volume":"7","author":"MA Teo","year":"2005","unstructured":"Teo MA, Shearwood C, Ng KC, Lu J, Moochhala S (2005) In vitro and in vivo characterization of MEMS microneedles. Biomed Microdevices 7:47\u201352","journal-title":"Biomed Microdevices"},{"key":"18_CR85_18","volume-title":"Physicians\u2019 desk reference","author":"PDR Thomson","year":"2007","unstructured":"Thomson PDR (2007) Physicians\u2019 desk reference. Thomson PDR, Montvale"},{"key":"18_CR86_18","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1038\/nbt1261","volume":"24","author":"JB Ulmer","year":"2006","unstructured":"Ulmer JB, Valley U, Rappuoli R (2006) Vaccine manufacturing: challenges and solutions. Nat Biotechnol 24:1377\u20131383","journal-title":"Nat Biotechnol"},{"key":"18_CR87_18","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.jconrel.2006.11.009","volume":"117","author":"FJ Verbaan","year":"2007","unstructured":"Verbaan FJ, Bal SM, van den Berg DJ, Groenink WH, Verpoorten H, Luttge R, Bouwstra JA (2007) Assembled microneedle arrays enhance the transport of compounds varying over a large range of molecular weight across human dermatomed skin. J Control Release 117:238\u2013245","journal-title":"J Control Release"},{"key":"18_CR88_18","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1089\/dia.2005.7.131","volume":"7","author":"P Wang","year":"2005","unstructured":"Wang P, Cornwell M, Prausnitz M (2005) Minimally invasive extraction of dermal interstitial fluid for glucose monitoring using glass microneedles. Diabetes Technol Ther 7:131\u2013141","journal-title":"Diabetes Technol Ther"},{"key":"18_CR89_18","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1038\/sj.jid.5700150","volume":"126","author":"PM Wang","year":"2006","unstructured":"Wang PM, Cornwell M, Hill J, Prausnitz MR (2006) Precise microinjection into skin using hollow microneedles. J Invest Dermatol 126:1080\u20131087","journal-title":"J Invest Dermatol"},{"key":"18_CR90_18","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1126\/science.1090350","volume":"302","author":"RJ Webby","year":"2003","unstructured":"Webby RJ, Webster RG (2003) Are we ready for pandemic influenza? Science 302:1519\u20131522","journal-title":"Science"},{"key":"18_CR91_18","volume-title":"Vaccines","author":"BG Weniger","year":"2008","unstructured":"Weniger BG, Papania M (2008) Alternative vaccine delivery methods. In: Plotkn S, Orenstein W, Offit P (eds) Vaccines. Elsevier, Philadelphia"},{"key":"18_CR92_18","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1016\/j.vaccine.2005.09.049","volume":"24","author":"G Widera","year":"2006","unstructured":"Widera G, Johnson J, Kim L, Libiran L, Nyam K, Daddona PE, Cormier M (2006) Effect of delivery parameters on immunization to ovalbumin following intracutaneous administration by a coated microneedle array patch system. Vaccine 24:1653\u20131664","journal-title":"Vaccine"},{"key":"18_CR93_18","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1016\/j.vaccine.2006.09.046","volume":"25","author":"I Wiser","year":"2007","unstructured":"Wiser I, Balicer RD, Cohen D (2007) An update on smallpox vaccine candidates and their role in bioterrorism related vaccination strategies. Vaccine 25:976\u2013984","journal-title":"Vaccine"},{"key":"18_CR94_18","first-page":"71","volume-title":"Models in dermatology","author":"DF Woodward","year":"1989","unstructured":"Woodward DF, Nieves AL, Williams LS, Spada CS, Hawley SB, Duenes JL (1989) A new hairless strain of guinea pig: characterization of the cutaneous morphology and pharmacology. In: Maibach HI, Lowe NJ (eds) Models in dermatology. Karger, Basel, pp 71\u201378","edition":"."},{"key":"18_CR95_18","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.ijpharm.2006.02.046","volume":"316","author":"XM Wu","year":"2006","unstructured":"Wu XM, Todo H, Sugibayashi K (2006) Effects of pretreatment of needle puncture and sandpaper abrasion on the in vitro skin permeation of fluorescein isothiocyanate (FITC)-dextran. Int J Pharm 316:102\u2013108","journal-title":"Int J Pharm"},{"key":"18_CR96_18","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.jconrel.2006.12.017","volume":"118","author":"XM Wu","year":"2007","unstructured":"Wu XM, Todo H, Sugibayashi K (2007) Enhancement of skin permeation of high molecular compounds by a combination of microneedle pretreatment and iontophoresis. J Control Release 118:189\u2013195","journal-title":"J Control Release"},{"key":"18_CR97_18","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.nano.2005.03.001","volume":"1","author":"Y Xie","year":"2005","unstructured":"Xie Y, Xu B, Gao Y (2005) Controlled transdermal delivery of model drug compounds by MEMS microneedle array. Nanomedicine 1:184\u2013190","journal-title":"Nanomedicine"},{"key":"18_CR98_18","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1023\/B:BMMD.0000042046.07678.2e","volume":"6","author":"M Yang","year":"2004","unstructured":"Yang M, Zahn JD (2004) Microneedle insertion force reduction using vibratory actuation. Biomed Microdevices 6:177\u2013182","journal-title":"Biomed Microdevices"}],"container-title":["Current Topics in Microbiology and Immunology","Vaccines for Pandemic Influenza"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-540-92165-3_18.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,16]],"date-time":"2024-03-16T16:55:54Z","timestamp":1710608154000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-540-92165-3_18"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009]]},"ISBN":["9783540921646","9783540921653"],"references-count":98,"URL":"https:\/\/doi.org\/10.1007\/978-3-540-92165-3_18","relation":{},"ISSN":["0070-217X"],"issn-type":[{"value":"0070-217X","type":"print"}],"subject":[],"published":{"date-parts":[[2009]]}}}